

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.44802832 |
| 2 | regulation of chromatin binding (GO:0035561) | 5.24997098 |
| 3 | limb bud formation (GO:0060174) | 5.08383035 |
| 4 | sensory perception of smell (GO:0007608) | 4.77222291 |
| 5 | presynaptic membrane organization (GO:0097090) | 4.40218084 |
| 6 | axonal fasciculation (GO:0007413) | 4.38879415 |
| 7 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.37755902 |
| 8 | nucleobase catabolic process (GO:0046113) | 4.26429628 |
| 9 | dendritic spine morphogenesis (GO:0060997) | 4.25107345 |
| 10 | cellular response to prostaglandin stimulus (GO:0071379) | 4.21042441 |
| 11 | regulation of cell communication by electrical coupling (GO:0010649) | 4.19675811 |
| 12 | lateral sprouting from an epithelium (GO:0060601) | 4.19673109 |
| 13 | neural tube formation (GO:0001841) | 4.13818874 |
| 14 | cAMP catabolic process (GO:0006198) | 4.07671416 |
| 15 | auditory behavior (GO:0031223) | 4.07447011 |
| 16 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.06507087 |
| 17 | protein polyglutamylation (GO:0018095) | 4.03305816 |
| 18 | presynaptic membrane assembly (GO:0097105) | 4.01152717 |
| 19 | sympathetic nervous system development (GO:0048485) | 3.99381768 |
| 20 | neuron recognition (GO:0008038) | 3.97431544 |
| 21 | histone H2B ubiquitination (GO:0033523) | 3.94927458 |
| 22 | negative regulation of axon guidance (GO:1902668) | 3.90424709 |
| 23 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.86207570 |
| 24 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.81879850 |
| 25 | sequestering of actin monomers (GO:0042989) | 3.79949294 |
| 26 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.79164415 |
| 27 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.77372942 |
| 28 | cyclic nucleotide catabolic process (GO:0009214) | 3.71322123 |
| 29 | ovulation cycle (GO:0042698) | 3.70101881 |
| 30 | sensory perception of chemical stimulus (GO:0007606) | 3.67460438 |
| 31 | eyelid development in camera-type eye (GO:0061029) | 3.64111039 |
| 32 | ganglion development (GO:0061548) | 3.63987264 |
| 33 | somite development (GO:0061053) | 3.60898031 |
| 34 | regulation of synapse structural plasticity (GO:0051823) | 3.55376579 |
| 35 | behavioral response to ethanol (GO:0048149) | 3.52986933 |
| 36 | olfactory bulb development (GO:0021772) | 3.51782076 |
| 37 | regulation of axon guidance (GO:1902667) | 3.45581931 |
| 38 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.45547266 |
| 39 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 3.40237646 |
| 40 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.39039292 |
| 41 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.33961832 |
| 42 | synapse assembly (GO:0007416) | 3.33205568 |
| 43 | neurofilament cytoskeleton organization (GO:0060052) | 3.32762447 |
| 44 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.29551121 |
| 45 | postsynaptic membrane organization (GO:0001941) | 3.27912150 |
| 46 | dendrite morphogenesis (GO:0048813) | 3.26213136 |
| 47 | neuron cell-cell adhesion (GO:0007158) | 3.25774569 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 3.25378525 |
| 49 | facial nerve structural organization (GO:0021612) | 3.20878867 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.20708026 |
| 51 | vocalization behavior (GO:0071625) | 3.17632761 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16611128 |
| 53 | mechanosensory behavior (GO:0007638) | 3.16025511 |
| 54 | cGMP-mediated signaling (GO:0019934) | 3.15097138 |
| 55 | cornea development in camera-type eye (GO:0061303) | 3.13916593 |
| 56 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.13277970 |
| 57 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12556460 |
| 58 | spinal cord motor neuron differentiation (GO:0021522) | 3.09139078 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.09084954 |
| 60 | urinary tract smooth muscle contraction (GO:0014848) | 3.07900985 |
| 61 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.07379787 |
| 62 | protein localization to synapse (GO:0035418) | 3.04944102 |
| 63 | neuronal ion channel clustering (GO:0045161) | 3.01210245 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.01047779 |
| 65 | inositol phosphate catabolic process (GO:0071545) | 2.99986837 |
| 66 | negative regulation of axon extension (GO:0030517) | 2.99216988 |
| 67 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.98770047 |
| 68 | craniofacial suture morphogenesis (GO:0097094) | 2.98361120 |
| 69 | snRNA transcription (GO:0009301) | 2.96251069 |
| 70 | neuronal action potential (GO:0019228) | 2.96056378 |
| 71 | renal system development (GO:0072001) | 2.95642383 |
| 72 | short-term memory (GO:0007614) | 2.95448815 |
| 73 | spinal cord development (GO:0021510) | 2.95246129 |
| 74 | metanephric mesenchyme development (GO:0072075) | 2.94373232 |
| 75 | kidney mesenchyme development (GO:0072074) | 2.94175850 |
| 76 | peristalsis (GO:0030432) | 2.93496569 |
| 77 | negative regulation of mast cell activation (GO:0033004) | 2.92485735 |
| 78 | intraciliary transport (GO:0042073) | 2.90487545 |
| 79 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.89754796 |
| 80 | response to prostaglandin E (GO:0034695) | 2.89727244 |
| 81 | V(D)J recombination (GO:0033151) | 2.89673335 |
| 82 | neuromuscular synaptic transmission (GO:0007274) | 2.89343460 |
| 83 | glomerulus development (GO:0032835) | 2.88357053 |
| 84 | protein-DNA complex disassembly (GO:0032986) | 2.83369410 |
| 85 | nucleosome disassembly (GO:0006337) | 2.83369410 |
| 86 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.83025575 |
| 87 | nonmotile primary cilium assembly (GO:0035058) | 2.82932027 |
| 88 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.82764699 |
| 89 | axon extension (GO:0048675) | 2.82278752 |
| 90 | neural crest cell development (GO:0014032) | 2.81485802 |
| 91 | response to auditory stimulus (GO:0010996) | 2.80928667 |
| 92 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.80446566 |
| 93 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.79214011 |
| 94 | adult walking behavior (GO:0007628) | 2.79199129 |
| 95 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.78450950 |
| 96 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.77098286 |
| 97 | negative regulation of dendrite development (GO:2000171) | 2.76664092 |
| 98 | behavioral response to pain (GO:0048266) | 2.76491362 |
| 99 | nerve growth factor signaling pathway (GO:0038180) | 2.76177962 |
| 100 | mesenchymal cell development (GO:0014031) | 2.75647085 |
| 101 | regulation of cilium movement (GO:0003352) | 2.74762656 |
| 102 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.72534672 |
| 103 | forebrain neuron differentiation (GO:0021879) | 2.70048326 |
| 104 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.69804338 |
| 105 | radial glial cell differentiation (GO:0060019) | 2.69307122 |
| 106 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.68564425 |
| 107 | axon extension involved in axon guidance (GO:0048846) | 2.68564425 |
| 108 | tachykinin receptor signaling pathway (GO:0007217) | 2.66013198 |
| 109 | positive regulation of gastrulation (GO:2000543) | 2.65775657 |
| 110 | cardiac ventricle formation (GO:0003211) | 2.64928822 |
| 111 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.64884086 |
| 112 | bone trabecula formation (GO:0060346) | 2.64821425 |
| 113 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.64017559 |
| 114 | regulation of histone deacetylation (GO:0031063) | 2.63793455 |
| 115 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.63791654 |
| 116 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62960470 |
| 117 | regulation of dopamine secretion (GO:0014059) | 2.60411382 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.59977149 |
| 119 | sensory perception of taste (GO:0050909) | 2.59847870 |
| 120 | establishment of mitochondrion localization (GO:0051654) | 2.59536365 |
| 121 | negative regulation of axonogenesis (GO:0050771) | 2.59255026 |
| 122 | neuron migration (GO:0001764) | 2.57506465 |
| 123 | regulation of action potential (GO:0098900) | 2.57454240 |
| 124 | glutamate receptor signaling pathway (GO:0007215) | 2.55159499 |
| 125 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.55091462 |
| 126 | regulation of protein kinase A signaling (GO:0010738) | 2.53068574 |
| 127 | detection of light stimulus involved in visual perception (GO:0050908) | 2.51827092 |
| 128 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.51827092 |
| 129 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.51209032 |
| 130 | head development (GO:0060322) | 2.50525305 |
| 131 | axonogenesis (GO:0007409) | 2.50139098 |
| 132 | regulation of protein heterodimerization activity (GO:0043497) | 2.49855028 |
| 133 | kidney morphogenesis (GO:0060993) | 2.49615645 |
| 134 | protein heterotrimerization (GO:0070208) | 2.49420191 |
| 135 | cranial nerve structural organization (GO:0021604) | 2.48570737 |
| 136 | regulation of axon extension (GO:0030516) | 2.48104132 |
| 137 | regulation of extent of cell growth (GO:0061387) | 2.47727943 |
| 138 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.47313856 |
| 139 | cellular response to monoamine stimulus (GO:0071868) | 2.47291090 |
| 140 | cellular response to catecholamine stimulus (GO:0071870) | 2.47291090 |
| 141 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.47138160 |
| 142 | cell migration in hindbrain (GO:0021535) | 2.46039430 |
| 143 | negative chemotaxis (GO:0050919) | 2.45622713 |
| 144 | neuron-neuron synaptic transmission (GO:0007270) | 2.45525231 |
| 145 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230) | 2.44317734 |
| 146 | atrial cardiac muscle cell action potential (GO:0086014) | 2.44070703 |
| 147 | synapse organization (GO:0050808) | 2.43410314 |
| 148 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.43159588 |
| 149 | positive regulation of synapse assembly (GO:0051965) | 2.43103873 |
| 150 | protein localization to cilium (GO:0061512) | 2.43099266 |
| 151 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.42152723 |
| 152 | sulfation (GO:0051923) | 2.42022291 |
| 153 | negative regulation of microtubule polymerization (GO:0031115) | 2.41248140 |
| 154 | cardiac chamber formation (GO:0003207) | 2.40702085 |
| 155 | synaptic transmission, cholinergic (GO:0007271) | 2.40538251 |
| 156 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.40368552 |
| 157 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.40368552 |
| 158 | response to histamine (GO:0034776) | 2.40297736 |
| 159 | regulation of sequestering of triglyceride (GO:0010889) | 2.40045790 |
| 160 | endothelial cell differentiation (GO:0045446) | 2.39993881 |
| 161 | central nervous system neuron axonogenesis (GO:0021955) | 2.39436530 |
| 162 | negative regulation of glial cell proliferation (GO:0060253) | 2.39014629 |
| 163 | neuronal action potential propagation (GO:0019227) | 2.38819906 |
| 164 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.38816071 |
| 165 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.38486173 |
| 166 | retinal ganglion cell axon guidance (GO:0031290) | 2.38306920 |
| 167 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.37797035 |
| 168 | stem cell development (GO:0048864) | 2.37464598 |
| 169 | lymph vessel development (GO:0001945) | 2.37005470 |
| 170 | regulation of platelet aggregation (GO:0090330) | 2.35926962 |
| 171 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.35830982 |
| 172 | regulation of protein deacetylation (GO:0090311) | 2.35176575 |
| 173 | omega-hydroxylase P450 pathway (GO:0097267) | 2.34970453 |
| 174 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.33931715 |
| 175 | auditory receptor cell differentiation (GO:0042491) | 2.33801751 |
| 176 | germ cell migration (GO:0008354) | 2.33427815 |
| 177 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.33184531 |
| 178 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.32358606 |
| 179 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.31135728 |
| 180 | mitochondrion transport along microtubule (GO:0047497) | 2.31135728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.73485845 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.23941818 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.41026482 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.18386696 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08933533 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.77308911 |
| 7 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.63169119 |
| 8 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.60579051 |
| 9 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54943663 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54817071 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54817071 |
| 12 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.48671503 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.42424111 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.40354948 |
| 15 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29660152 |
| 16 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.21204841 |
| 17 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.19665661 |
| 18 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.15711629 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10565083 |
| 20 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08536975 |
| 21 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05768539 |
| 22 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03531263 |
| 23 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.01416022 |
| 24 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00889384 |
| 25 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.98749304 |
| 26 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97522951 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96719331 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96636135 |
| 29 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94477832 |
| 30 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78166552 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.78055482 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74727906 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74300136 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.73620749 |
| 35 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72861828 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.66175105 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65807573 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64716090 |
| 39 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64134283 |
| 40 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.62010763 |
| 41 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59376944 |
| 42 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.58786187 |
| 43 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55961830 |
| 44 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53717012 |
| 45 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.53607544 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47127919 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.45155927 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44057517 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43156474 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41732441 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38775183 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38524886 |
| 53 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36240814 |
| 54 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.36166701 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33816261 |
| 56 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33524720 |
| 57 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32522346 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32006173 |
| 59 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29446220 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28801709 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28747340 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26952889 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26437895 |
| 64 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26107668 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23606163 |
| 66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23295594 |
| 67 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22880150 |
| 68 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22880150 |
| 69 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22517646 |
| 70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21713063 |
| 71 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21060251 |
| 72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.20757279 |
| 73 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17026791 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.15350490 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.15350490 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15118668 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13508989 |
| 78 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13242654 |
| 79 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.12089004 |
| 80 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10412049 |
| 81 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.10287818 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09421183 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08249230 |
| 84 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07877145 |
| 85 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07617787 |
| 86 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04718670 |
| 87 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03104901 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02312706 |
| 89 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02182372 |
| 90 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99867419 |
| 91 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99135721 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97565337 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97304150 |
| 94 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97256642 |
| 95 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96796467 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96245925 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96032848 |
| 98 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95107091 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94650498 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93983519 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93663596 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92747277 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92160976 |
| 104 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91297944 |
| 105 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91161576 |
| 106 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.90252458 |
| 107 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89783646 |
| 108 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.89547203 |
| 109 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88220428 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88150363 |
| 111 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.86615752 |
| 112 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86584245 |
| 113 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86295532 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86136584 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85636606 |
| 116 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85546491 |
| 117 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85190305 |
| 118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.83805587 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83142465 |
| 120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82987727 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 0.82878660 |
| 122 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.82256522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008789_abnormal_olfactory_epithelium | 5.13831103 |
| 2 | MP0005499_abnormal_olfactory_system | 4.22270162 |
| 3 | MP0005394_taste/olfaction_phenotype | 4.22270162 |
| 4 | MP0001984_abnormal_olfaction | 3.80259673 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.76008551 |
| 6 | MP0002822_catalepsy | 3.59957759 |
| 7 | MP0006276_abnormal_autonomic_nervous | 2.92897897 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.68091670 |
| 9 | MP0002938_white_spotting | 2.67963098 |
| 10 | MP0001188_hyperpigmentation | 2.63096192 |
| 11 | MP0002102_abnormal_ear_morphology | 2.62844130 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.53663625 |
| 13 | MP0002638_abnormal_pupillary_reflex | 2.29361173 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.26851925 |
| 15 | MP0009250_abnormal_appendicular_skeleto | 2.25256792 |
| 16 | MP0002751_abnormal_autonomic_nervous | 2.22124431 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.21483563 |
| 18 | MP0003011_delayed_dark_adaptation | 2.17266929 |
| 19 | MP0004134_abnormal_chest_morphology | 2.14709527 |
| 20 | MP0002160_abnormal_reproductive_system | 2.09989961 |
| 21 | MP0001542_abnormal_bone_strength | 2.07291093 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.97824108 |
| 23 | MP0002184_abnormal_innervation | 1.89796948 |
| 24 | MP0003635_abnormal_synaptic_transmissio | 1.86773149 |
| 25 | MP0009745_abnormal_behavioral_response | 1.79313364 |
| 26 | MP0004270_analgesia | 1.79104669 |
| 27 | MP0003787_abnormal_imprinting | 1.78717602 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.75105324 |
| 29 | MP0002233_abnormal_nose_morphology | 1.72417399 |
| 30 | MP0000049_abnormal_middle_ear | 1.72351545 |
| 31 | * MP0000778_abnormal_nervous_system | 1.72236547 |
| 32 | MP0001529_abnormal_vocalization | 1.65899979 |
| 33 | MP0005275_abnormal_skin_tensile | 1.64425152 |
| 34 | MP0009046_muscle_twitch | 1.62318759 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.60908313 |
| 36 | MP0001299_abnormal_eye_distance/ | 1.58739786 |
| 37 | MP0000003_abnormal_adipose_tissue | 1.57242009 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.56864436 |
| 39 | MP0000566_synostosis | 1.56249794 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.53949059 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.53151278 |
| 42 | MP0002249_abnormal_larynx_morphology | 1.52558805 |
| 43 | MP0002928_abnormal_bile_duct | 1.50867523 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.50147136 |
| 45 | MP0004885_abnormal_endolymph | 1.49387178 |
| 46 | MP0005409_darkened_coat_color | 1.46191231 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.43895260 |
| 48 | MP0004130_abnormal_muscle_cell | 1.42102953 |
| 49 | MP0003385_abnormal_body_wall | 1.41102521 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.40942295 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.40360105 |
| 52 | MP0000955_abnormal_spinal_cord | 1.38289057 |
| 53 | MP0002064_seizures | 1.37291011 |
| 54 | MP0002932_abnormal_joint_morphology | 1.36859804 |
| 55 | MP0005171_absent_coat_pigmentation | 1.36408822 |
| 56 | MP0001970_abnormal_pain_threshold | 1.34953376 |
| 57 | MP0001440_abnormal_grooming_behavior | 1.34464050 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.33068120 |
| 59 | MP0002177_abnormal_outer_ear | 1.31777230 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.31075319 |
| 61 | MP0002734_abnormal_mechanical_nocicepti | 1.30832028 |
| 62 | MP0003942_abnormal_urinary_system | 1.30343976 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.30013401 |
| 64 | MP0004924_abnormal_behavior | 1.30013401 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.29959098 |
| 66 | MP0004133_heterotaxia | 1.29398138 |
| 67 | MP0002116_abnormal_craniofacial_bone | 1.28261574 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.28058081 |
| 69 | MP0003315_abnormal_perineum_morphology | 1.24403149 |
| 70 | MP0002733_abnormal_thermal_nociception | 1.23812783 |
| 71 | MP0005389_reproductive_system_phenotype | 1.23546966 |
| 72 | MP0001293_anophthalmia | 1.23169843 |
| 73 | MP0005670_abnormal_white_adipose | 1.21989265 |
| 74 | MP0005187_abnormal_penis_morphology | 1.21014017 |
| 75 | MP0003755_abnormal_palate_morphology | 1.20356439 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 1.19068468 |
| 77 | MP0003122_maternal_imprinting | 1.18786814 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 1.18527921 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.17510058 |
| 80 | MP0003935_abnormal_craniofacial_develop | 1.17501451 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.16321149 |
| 82 | MP0002282_abnormal_trachea_morphology | 1.11177623 |
| 83 | MP0009379_abnormal_foot_pigmentation | 1.11165117 |
| 84 | MP0005623_abnormal_meninges_morphology | 1.10826500 |
| 85 | MP0003938_abnormal_ear_development | 1.10730554 |
| 86 | MP0005508_abnormal_skeleton_morphology | 1.09756622 |
| 87 | MP0002752_abnormal_somatic_nervous | 1.09509201 |
| 88 | MP0003121_genomic_imprinting | 1.08955257 |
| 89 | MP0003283_abnormal_digestive_organ | 1.08478152 |
| 90 | MP0005253_abnormal_eye_physiology | 1.07627518 |
| 91 | MP0002653_abnormal_ependyma_morphology | 1.07531800 |
| 92 | MP0000026_abnormal_inner_ear | 1.06727604 |
| 93 | MP0001905_abnormal_dopamine_level | 1.06150837 |
| 94 | MP0002009_preneoplasia | 1.06013049 |
| 95 | MP0004142_abnormal_muscle_tone | 1.03690274 |
| 96 | MP0005174_abnormal_tail_pigmentation | 1.01948888 |
| 97 | MP0006072_abnormal_retinal_apoptosis | 1.01805354 |
| 98 | * MP0003861_abnormal_nervous_system | 0.99465170 |
| 99 | MP0004381_abnormal_hair_follicle | 0.98178287 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.97844036 |
| 101 | MP0002882_abnormal_neuron_morphology | 0.97671062 |
| 102 | MP0005195_abnormal_posterior_eye | 0.97176182 |
| 103 | MP0000751_myopathy | 0.96011383 |
| 104 | MP0002109_abnormal_limb_morphology | 0.94551684 |
| 105 | MP0000538_abnormal_urinary_bladder | 0.93011301 |
| 106 | MP0001968_abnormal_touch/_nociception | 0.91720737 |
| 107 | MP0002108_abnormal_muscle_morphology | 0.91096882 |
| 108 | MP0004858_abnormal_nervous_system | 0.90769127 |
| 109 | MP0003119_abnormal_digestive_system | 0.90689490 |
| 110 | MP0002736_abnormal_nociception_after | 0.90475958 |
| 111 | MP0003937_abnormal_limbs/digits/tail_de | 0.89700477 |
| 112 | MP0003890_abnormal_embryonic-extraembry | 0.89297008 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.89275128 |
| 114 | MP0000427_abnormal_hair_cycle | 0.88600563 |
| 115 | MP0000534_abnormal_ureter_morphology | 0.87502208 |
| 116 | MP0008995_early_reproductive_senescence | 0.87150522 |
| 117 | MP0001286_abnormal_eye_development | 0.86999475 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.86798727 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.86638186 |
| 120 | MP0001340_abnormal_eyelid_morphology | 0.85431801 |
| 121 | MP0004272_abnormal_basement_membrane | 0.85373031 |
| 122 | MP0001485_abnormal_pinna_reflex | 0.84776781 |
| 123 | MP0001958_emphysema | 0.84760364 |
| 124 | MP0010030_abnormal_orbit_morphology | 0.84661521 |
| 125 | MP0008569_lethality_at_weaning | 0.82320940 |
| 126 | MP0002066_abnormal_motor_capabilities/c | 0.82248922 |
| 127 | MP0005367_renal/urinary_system_phenotyp | 0.81464553 |
| 128 | MP0000516_abnormal_urinary_system | 0.81464553 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.81275820 |
| 130 | MP0002067_abnormal_sensory_capabilities | 0.81195743 |
| 131 | * MP0002115_abnormal_skeleton_extremities | 0.80911407 |
| 132 | MP0002132_abnormal_respiratory_system | 0.80315679 |
| 133 | MP0004742_abnormal_vestibular_system | 0.79970081 |
| 134 | MP0002114_abnormal_axial_skeleton | 0.79930277 |
| 135 | MP0005646_abnormal_pituitary_gland | 0.79560238 |
| 136 | MP0002081_perinatal_lethality | 0.79325053 |
| 137 | * MP0000163_abnormal_cartilage_morphology | 0.78676967 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.78031062 |
| 139 | MP0002272_abnormal_nervous_system | 0.77883960 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.77542858 |
| 141 | MP0001919_abnormal_reproductive_system | 0.77525942 |
| 142 | MP0000432_abnormal_head_morphology | 0.77435198 |
| 143 | MP0000762_abnormal_tongue_morphology | 0.75576800 |
| 144 | MP0003959_abnormal_lean_body | 0.74811622 |
| 145 | MP0004883_abnormal_blood_vessel | 0.74054489 |
| 146 | MP0009384_cardiac_valve_regurgitation | 0.73854491 |
| 147 | MP0003136_yellow_coat_color | 0.71207869 |
| 148 | MP0009703_decreased_birth_body | 0.70817620 |
| 149 | MP0003279_aneurysm | 0.70527815 |
| 150 | MP0000647_abnormal_sebaceous_gland | 0.70483373 |
| 151 | MP0002095_abnormal_skin_pigmentation | 0.70471217 |
| 152 | * MP0002152_abnormal_brain_morphology | 0.70154630 |
| 153 | MP0001486_abnormal_startle_reflex | 0.68979698 |
| 154 | MP0003880_abnormal_central_pattern | 0.68278445 |
| 155 | * MP0002113_abnormal_skeleton_development | 0.66859499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 5.83033103 |
| 2 | Midline defect of the nose (HP:0004122) | 4.36684117 |
| 3 | Trigonocephaly (HP:0000243) | 4.18871606 |
| 4 | Febrile seizures (HP:0002373) | 4.05951912 |
| 5 | Xerostomia (HP:0000217) | 3.77233607 |
| 6 | Abnormality of the parietal bone (HP:0002696) | 3.64906412 |
| 7 | Ulnar claw (HP:0001178) | 3.51443489 |
| 8 | Abnormality of the intervertebral disk (HP:0005108) | 3.39645407 |
| 9 | Thyroiditis (HP:0100646) | 3.28926279 |
| 10 | Focal motor seizures (HP:0011153) | 3.19047130 |
| 11 | Broad-based gait (HP:0002136) | 3.16124369 |
| 12 | Anosmia (HP:0000458) | 3.14068974 |
| 13 | Concave nail (HP:0001598) | 3.13039406 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.11772769 |
| 15 | Asymmetry of the thorax (HP:0001555) | 3.10214858 |
| 16 | Nasolacrimal duct obstruction (HP:0000579) | 2.93500579 |
| 17 | Congenital stationary night blindness (HP:0007642) | 2.90215017 |
| 18 | Pachygyria (HP:0001302) | 2.88469304 |
| 19 | Abnormality of incisor morphology (HP:0011063) | 2.86389172 |
| 20 | Bell-shaped thorax (HP:0001591) | 2.82230220 |
| 21 | Atonic seizures (HP:0010819) | 2.81156027 |
| 22 | Limb dystonia (HP:0002451) | 2.81013517 |
| 23 | Pancreatic cysts (HP:0001737) | 2.77916329 |
| 24 | Bradycardia (HP:0001662) | 2.73341226 |
| 25 | Myokymia (HP:0002411) | 2.71920420 |
| 26 | Keratoconus (HP:0000563) | 2.70670231 |
| 27 | Increased corneal curvature (HP:0100692) | 2.70670231 |
| 28 | Genetic anticipation (HP:0003743) | 2.70276713 |
| 29 | Drooling (HP:0002307) | 2.69906461 |
| 30 | Slow-growing hair (HP:0002217) | 2.68022366 |
| 31 | Abnormality of hair growth rate (HP:0011363) | 2.68022366 |
| 32 | Wrist flexion contracture (HP:0001239) | 2.65888342 |
| 33 | Sparse lateral eyebrow (HP:0005338) | 2.64888675 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 2.64371976 |
| 35 | True hermaphroditism (HP:0010459) | 2.57838214 |
| 36 | Abnormality of the renal medulla (HP:0100957) | 2.57187466 |
| 37 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.56369523 |
| 38 | Hypoplasia of the brainstem (HP:0002365) | 2.56369523 |
| 39 | Amblyopia (HP:0000646) | 2.55537744 |
| 40 | Polyphagia (HP:0002591) | 2.54888918 |
| 41 | Abnormality of the nasolacrimal system (HP:0000614) | 2.53628925 |
| 42 | Chronic hepatic failure (HP:0100626) | 2.48278312 |
| 43 | Exotropia (HP:0000577) | 2.47689739 |
| 44 | Long nose (HP:0003189) | 2.47660329 |
| 45 | Excessive salivation (HP:0003781) | 2.46268733 |
| 46 | Hemiparesis (HP:0001269) | 2.46019425 |
| 47 | Hyperventilation (HP:0002883) | 2.43937492 |
| 48 | Lissencephaly (HP:0001339) | 2.43309941 |
| 49 | Large earlobe (HP:0009748) | 2.42968669 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.42736788 |
| 51 | Congenital, generalized hypertrichosis (HP:0004540) | 2.42489338 |
| 52 | Intellectual disability, moderate (HP:0002342) | 2.41633757 |
| 53 | Abnormality of the columella (HP:0009929) | 2.40726378 |
| 54 | Abnormality of the lacrimal duct (HP:0011481) | 2.36349023 |
| 55 | Median cleft lip (HP:0000161) | 2.34969084 |
| 56 | Gait imbalance (HP:0002141) | 2.30757717 |
| 57 | Aqueductal stenosis (HP:0002410) | 2.29860783 |
| 58 | Short 4th metacarpal (HP:0010044) | 2.28933037 |
| 59 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.28933037 |
| 60 | Arthropathy (HP:0003040) | 2.26540000 |
| 61 | Aplasia cutis congenita (HP:0001057) | 2.25369341 |
| 62 | Alacrima (HP:0000522) | 2.25354415 |
| 63 | Deep philtrum (HP:0002002) | 2.21564302 |
| 64 | White forelock (HP:0002211) | 2.20124904 |
| 65 | Chorioretinal atrophy (HP:0000533) | 2.19488302 |
| 66 | Anencephaly (HP:0002323) | 2.18737554 |
| 67 | Fair hair (HP:0002286) | 2.17752435 |
| 68 | Epileptic encephalopathy (HP:0200134) | 2.16556295 |
| 69 | Absence seizures (HP:0002121) | 2.14144556 |
| 70 | High anterior hairline (HP:0009890) | 2.12869523 |
| 71 | Verrucae (HP:0200043) | 2.11930888 |
| 72 | Papilloma (HP:0012740) | 2.11930888 |
| 73 | Abnormality of dentin (HP:0010299) | 2.11884061 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.11220046 |
| 75 | Abnormality of the nasal septum (HP:0000419) | 2.10267197 |
| 76 | Abnormality of B cell number (HP:0010975) | 2.09612611 |
| 77 | Inability to walk (HP:0002540) | 2.08100626 |
| 78 | Prominent supraorbital ridges (HP:0000336) | 2.07914094 |
| 79 | Heterochromia iridis (HP:0001100) | 2.07055114 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07036522 |
| 81 | B lymphocytopenia (HP:0010976) | 2.05022690 |
| 82 | Abnormality of the incisor (HP:0000676) | 2.04921822 |
| 83 | Congenital primary aphakia (HP:0007707) | 2.04469253 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.02886885 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.02886885 |
| 86 | Dialeptic seizures (HP:0011146) | 2.02489171 |
| 87 | Patchy hypopigmentation of hair (HP:0011365) | 2.01375439 |
| 88 | Abnormality of the corticospinal tract (HP:0002492) | 2.01329390 |
| 89 | Anterior segment dysgenesis (HP:0007700) | 2.00524456 |
| 90 | Pendular nystagmus (HP:0012043) | 2.00354096 |
| 91 | Abnormality of molar morphology (HP:0011070) | 1.99974936 |
| 92 | Abnormality of molar (HP:0011077) | 1.99974936 |
| 93 | Increased number of teeth (HP:0011069) | 1.99898335 |
| 94 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.99425325 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 1.98570163 |
| 96 | Striae distensae (HP:0001065) | 1.98088956 |
| 97 | Absent speech (HP:0001344) | 1.97386736 |
| 98 | Broad metatarsal (HP:0001783) | 1.97331112 |
| 99 | Steppage gait (HP:0003376) | 1.96777517 |
| 100 | Agitation (HP:0000713) | 1.96428143 |
| 101 | Pancreatic fibrosis (HP:0100732) | 1.95988128 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 1.94855578 |
| 103 | Palpebral edema (HP:0100540) | 1.94388868 |
| 104 | Abnormal eating behavior (HP:0100738) | 1.94276280 |
| 105 | Hypoventilation (HP:0002791) | 1.93734231 |
| 106 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.91166895 |
| 107 | Vertebral arch anomaly (HP:0008438) | 1.91136799 |
| 108 | Action tremor (HP:0002345) | 1.90091629 |
| 109 | Microglossia (HP:0000171) | 1.89556692 |
| 110 | Genital tract atresia (HP:0001827) | 1.88978082 |
| 111 | Generalized tonic-clonic seizures (HP:0002069) | 1.87190183 |
| 112 | Retinal dysplasia (HP:0007973) | 1.86970323 |
| 113 | Oligodactyly (hands) (HP:0001180) | 1.86309621 |
| 114 | Cortical dysplasia (HP:0002539) | 1.86069920 |
| 115 | Severe combined immunodeficiency (HP:0004430) | 1.85739852 |
| 116 | Mesomelia (HP:0003027) | 1.84588480 |
| 117 | Preaxial hand polydactyly (HP:0001177) | 1.84547112 |
| 118 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.84323461 |
| 119 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.84044040 |
| 120 | Short tibia (HP:0005736) | 1.83544056 |
| 121 | Nephronophthisis (HP:0000090) | 1.83483361 |
| 122 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.82712585 |
| 123 | Incomplete penetrance (HP:0003829) | 1.82177523 |
| 124 | Overgrowth (HP:0001548) | 1.81968270 |
| 125 | Vaginal atresia (HP:0000148) | 1.81782382 |
| 126 | Curly hair (HP:0002212) | 1.81607070 |
| 127 | Bulbous nose (HP:0000414) | 1.81426221 |
| 128 | Vitreoretinal degeneration (HP:0000655) | 1.80912667 |
| 129 | Type II lissencephaly (HP:0007260) | 1.80896740 |
| 130 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.79035067 |
| 131 | Cellulitis (HP:0100658) | 1.78898536 |
| 132 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.76619941 |
| 133 | Furrowed tongue (HP:0000221) | 1.75422907 |
| 134 | Toxemia of pregnancy (HP:0100603) | 1.75356407 |
| 135 | Hemiplegia (HP:0002301) | 1.75160543 |
| 136 | Abnormal number of incisors (HP:0011064) | 1.75039916 |
| 137 | Abnormality of permanent molar morphology (HP:0011071) | 1.74820106 |
| 138 | Abnormality of the dental root (HP:0006486) | 1.74820106 |
| 139 | Taurodontia (HP:0000679) | 1.74820106 |
| 140 | Decreased lacrimation (HP:0000633) | 1.74795368 |
| 141 | Tubulointerstitial fibrosis (HP:0005576) | 1.74585373 |
| 142 | Abnormality of the ischium (HP:0003174) | 1.74466602 |
| 143 | Supernumerary spleens (HP:0009799) | 1.74452714 |
| 144 | Synostosis involving the elbow (HP:0003938) | 1.73013557 |
| 145 | Humeroradial synostosis (HP:0003041) | 1.73013557 |
| 146 | Specific learning disability (HP:0001328) | 1.73001808 |
| 147 | Abnormality of salivation (HP:0100755) | 1.72725069 |
| 148 | Decreased circulating renin level (HP:0003351) | 1.72525840 |
| 149 | Molar tooth sign on MRI (HP:0002419) | 1.72248010 |
| 150 | Abnormality of midbrain morphology (HP:0002418) | 1.72248010 |
| 151 | Tubulointerstitial nephritis (HP:0001970) | 1.71871509 |
| 152 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.70869107 |
| 153 | Optic nerve hypoplasia (HP:0000609) | 1.70839924 |
| 154 | Cutaneous syndactyly (HP:0012725) | 1.70788519 |
| 155 | Polymicrogyria (HP:0002126) | 1.70663800 |
| 156 | Hypoplasia of the thymus (HP:0000778) | 1.70312619 |
| 157 | Impaired pain sensation (HP:0007328) | 1.70284733 |
| 158 | Abnormality of pain sensation (HP:0010832) | 1.70284733 |
| 159 | Chronic sinusitis (HP:0011109) | 1.69913845 |
| 160 | Pheochromocytoma (HP:0002666) | 1.69533799 |
| 161 | Morphological abnormality of the middle ear (HP:0008609) | 1.67685779 |
| 162 | Cystic liver disease (HP:0006706) | 1.67636040 |
| 163 | Abnormality of the diencephalon (HP:0010662) | 1.67508066 |
| 164 | Recurrent pneumonia (HP:0006532) | 1.67489967 |
| 165 | Anteriorly placed anus (HP:0001545) | 1.67411315 |
| 166 | Infantile muscular hypotonia (HP:0008947) | 1.66028716 |
| 167 | Accelerated skeletal maturation (HP:0005616) | 1.65735376 |
| 168 | Focal seizures (HP:0007359) | 1.65101510 |
| 169 | Pulmonary artery stenosis (HP:0004415) | 1.64698936 |
| 170 | Wormian bones (HP:0002645) | 1.64343019 |
| 171 | Blue irides (HP:0000635) | 1.63613230 |
| 172 | Recurrent corneal erosions (HP:0000495) | 1.63534673 |
| 173 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.62149028 |
| 174 | Depressed nasal tip (HP:0000437) | 1.61486076 |
| 175 | Mask-like facies (HP:0000298) | 1.60473082 |
| 176 | Postaxial hand polydactyly (HP:0001162) | 1.59353115 |
| 177 | Constricted visual fields (HP:0001133) | 1.58726882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 4.68726487 |
| 2 | MAPK13 | 4.24022308 |
| 3 | MAPKAPK3 | 4.08033555 |
| 4 | CASK | 3.70093544 |
| 5 | ERBB3 | 3.11146043 |
| 6 | SRPK1 | 2.77610911 |
| 7 | TIE1 | 2.67740108 |
| 8 | BMPR2 | 2.26539294 |
| 9 | TLK1 | 2.23494002 |
| 10 | MAP3K10 | 2.23301372 |
| 11 | TRPM7 | 1.92754624 |
| 12 | DYRK2 | 1.92037953 |
| 13 | BMPR1B | 1.87744657 |
| 14 | KIT | 1.83621182 |
| 15 | NLK | 1.75061504 |
| 16 | TNK2 | 1.73481753 |
| 17 | FGFR2 | 1.72785328 |
| 18 | MAP2K7 | 1.71550075 |
| 19 | DYRK3 | 1.70392846 |
| 20 | MAPKAPK5 | 1.69513822 |
| 21 | PAK3 | 1.64685242 |
| 22 | WNK3 | 1.59944711 |
| 23 | PNCK | 1.59523245 |
| 24 | BCR | 1.58924656 |
| 25 | MKNK2 | 1.58571351 |
| 26 | PINK1 | 1.54797026 |
| 27 | YES1 | 1.54047299 |
| 28 | SGK494 | 1.43301481 |
| 29 | SGK223 | 1.43301481 |
| 30 | CAMK1G | 1.35076908 |
| 31 | SIK1 | 1.30126121 |
| 32 | PLK4 | 1.28546996 |
| 33 | MARK2 | 1.28158447 |
| 34 | PRPF4B | 1.25662117 |
| 35 | DAPK2 | 1.25485179 |
| 36 | SGK2 | 1.22489114 |
| 37 | FER | 1.18458508 |
| 38 | UHMK1 | 1.18329670 |
| 39 | SIK3 | 1.17896266 |
| 40 | MAPK12 | 1.16072073 |
| 41 | TGFBR1 | 1.15822904 |
| 42 | MAP4K2 | 1.15311187 |
| 43 | MARK1 | 1.15188070 |
| 44 | RPS6KA2 | 1.11854501 |
| 45 | RPS6KB2 | 1.11675141 |
| 46 | TNIK | 1.09404933 |
| 47 | CSNK1A1L | 1.09038954 |
| 48 | PHKG1 | 1.08230462 |
| 49 | PHKG2 | 1.08230462 |
| 50 | AKT3 | 1.06374396 |
| 51 | GRK1 | 1.02208716 |
| 52 | MAP2K4 | 0.97652463 |
| 53 | EIF2AK2 | 0.97456155 |
| 54 | DDR2 | 0.96097854 |
| 55 | SIK2 | 0.96066030 |
| 56 | RPS6KB1 | 0.93976286 |
| 57 | NTRK1 | 0.93499820 |
| 58 | TAF1 | 0.92983321 |
| 59 | PLK2 | 0.92809017 |
| 60 | CDK5 | 0.91042268 |
| 61 | MINK1 | 0.90284988 |
| 62 | TYRO3 | 0.87612092 |
| 63 | MKNK1 | 0.86602336 |
| 64 | HIPK2 | 0.83627060 |
| 65 | NTRK2 | 0.83124552 |
| 66 | WNK4 | 0.82521703 |
| 67 | PRKG1 | 0.80663868 |
| 68 | EPHB2 | 0.79870197 |
| 69 | CAMK1D | 0.78213758 |
| 70 | CSNK1G1 | 0.77873231 |
| 71 | TGFBR2 | 0.77168241 |
| 72 | INSRR | 0.76869888 |
| 73 | MAP3K6 | 0.75801247 |
| 74 | FES | 0.74161479 |
| 75 | CDK9 | 0.74073991 |
| 76 | SGK3 | 0.72799516 |
| 77 | STK11 | 0.69641757 |
| 78 | FGFR3 | 0.69485443 |
| 79 | MAPK4 | 0.69411418 |
| 80 | DYRK1B | 0.68620740 |
| 81 | CSNK1G3 | 0.68290839 |
| 82 | MAPK11 | 0.67613375 |
| 83 | WNK1 | 0.67380987 |
| 84 | MAPK15 | 0.65203267 |
| 85 | STK24 | 0.64514210 |
| 86 | FRK | 0.63946305 |
| 87 | ADRBK2 | 0.63673724 |
| 88 | TRIM28 | 0.62291342 |
| 89 | PRKCE | 0.62085792 |
| 90 | GRK5 | 0.60915772 |
| 91 | CAMK2A | 0.60207208 |
| 92 | CAMK1 | 0.59862934 |
| 93 | ZAK | 0.59277264 |
| 94 | EPHA4 | 0.58914221 |
| 95 | NEK9 | 0.57284684 |
| 96 | KSR1 | 0.56005609 |
| 97 | CAMK4 | 0.55917132 |
| 98 | MAPKAPK2 | 0.53415812 |
| 99 | GRK6 | 0.53402724 |
| 100 | PRKACA | 0.52343584 |
| 101 | PRKCG | 0.51410496 |
| 102 | EPHA3 | 0.50826230 |
| 103 | PRKAA1 | 0.50546559 |
| 104 | PRKCQ | 0.49353673 |
| 105 | DYRK1A | 0.48839117 |
| 106 | AURKA | 0.48197942 |
| 107 | CSF1R | 0.47781905 |
| 108 | OXSR1 | 0.47733194 |
| 109 | IRAK4 | 0.46977173 |
| 110 | CAMK2B | 0.46836984 |
| 111 | STK39 | 0.45827347 |
| 112 | CSNK1G2 | 0.45159113 |
| 113 | PRKCZ | 0.45108572 |
| 114 | PRKD2 | 0.44529146 |
| 115 | MAPK7 | 0.42895702 |
| 116 | PRKCH | 0.42013962 |
| 117 | NUAK1 | 0.41709136 |
| 118 | ROCK2 | 0.41563507 |
| 119 | STK38L | 0.40605654 |
| 120 | VRK1 | 0.40214653 |
| 121 | PRKAA2 | 0.39871561 |
| 122 | CSNK1D | 0.39360207 |
| 123 | OBSCN | 0.39282870 |
| 124 | PRKACB | 0.39238752 |
| 125 | CAMK2D | 0.38260437 |
| 126 | ADRBK1 | 0.38030778 |
| 127 | ROCK1 | 0.38007041 |
| 128 | CDK3 | 0.37819556 |
| 129 | CDK8 | 0.37471384 |
| 130 | PRKD1 | 0.37185246 |
| 131 | SYK | 0.36173392 |
| 132 | DAPK3 | 0.34731006 |
| 133 | MAP3K4 | 0.34457049 |
| 134 | PKN1 | 0.34446426 |
| 135 | PDGFRA | 0.33126326 |
| 136 | RPS6KA4 | 0.33039922 |
| 137 | INSR | 0.32112279 |
| 138 | CAMKK2 | 0.32026203 |
| 139 | IRAK1 | 0.31254662 |
| 140 | ACVR1B | 0.31172050 |
| 141 | LIMK1 | 0.30534746 |
| 142 | MAP2K1 | 0.30394725 |
| 143 | DAPK1 | 0.30380111 |
| 144 | NTRK3 | 0.30049087 |
| 145 | RPS6KA3 | 0.29853269 |
| 146 | MST4 | 0.29377009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 4.71196482 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.58926402 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.00507863 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 2.03115690 |
| 5 | Cocaine addiction_Homo sapiens_hsa05030 | 2.01977063 |
| 6 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.84064197 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.80168939 |
| 8 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.78712484 |
| 9 | Alcoholism_Homo sapiens_hsa05034 | 1.75147462 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 1.71538071 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 1.70190005 |
| 12 | Melanoma_Homo sapiens_hsa05218 | 1.60923169 |
| 13 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.60199850 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54174538 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52797524 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51089727 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.45035584 |
| 18 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.44261199 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.43209163 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41910884 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41172066 |
| 22 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.40038580 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39028595 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36077932 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.35914090 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33786461 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32566459 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.32189859 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.26146405 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.23599863 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.22689453 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20825102 |
| 33 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.18647783 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.18430176 |
| 35 | Colorectal cancer_Homo sapiens_hsa05210 | 1.17616623 |
| 36 | Pathways in cancer_Homo sapiens_hsa05200 | 1.17083204 |
| 37 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16859682 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16790286 |
| 39 | Prostate cancer_Homo sapiens_hsa05215 | 1.13839491 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.13227381 |
| 41 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.12457894 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.12128525 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.10534226 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06938152 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05568591 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05121758 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.03241644 |
| 48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.02708983 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01931909 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00901399 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00839092 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.00654640 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98768291 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96859641 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94366574 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94260357 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93078009 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91294092 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91127813 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91113791 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.89747262 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89227042 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87622255 |
| 64 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.87461784 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86446389 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85818573 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81267526 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81246225 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80750433 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80377777 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79769668 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79526374 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79389686 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78596855 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78422152 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78163901 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.76257502 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75482756 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75031630 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74702098 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74241654 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73800912 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73563748 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72759602 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72712288 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71200525 |
| 87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70782719 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69995140 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.65223974 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.64651196 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64365930 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63402815 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63257504 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.62525882 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62259327 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.61694513 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61689208 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.61666208 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61267157 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60846751 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60240249 |
| 102 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58859870 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58775291 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58066805 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57680194 |
| 106 | Spliceosome_Homo sapiens_hsa03040 | 0.57030287 |
| 107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56583166 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56399770 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54157018 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.54055467 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53409617 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52951371 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51759304 |
| 114 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51598386 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51131360 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50897210 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50396121 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.50141494 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48690870 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47167488 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46782337 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46550516 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45926038 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45460526 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.44328508 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43379362 |
| 127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43372565 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43275966 |
| 129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43181380 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42730289 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42531574 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42484306 |
| 133 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41988864 |
| 134 | Base excision repair_Homo sapiens_hsa03410 | 0.41972513 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41954954 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41482321 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41227193 |
| 138 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40762398 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.40057082 |
| 140 | Protein export_Homo sapiens_hsa03060 | 0.40030811 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37626394 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37503980 |
| 143 | Phagosome_Homo sapiens_hsa04145 | 0.37133388 |

